Latest
Aumolertinib and Sugemalimab have both shown positive data from Phase III studies in treatment of non-small cell lung cancer and could offer treatment at a fraction of the cost of existing and traditional approaches EQRx is committed to developing new medicines, offering them at lower prices, reimagining medicine to address one of society’s biggest health […]
...Holoeyes’ virtual reality platform fuses technology and medicine enabling medical staff to share complex information intuitively and with greater understanding and transparency than conventional 2D imaging techniques Remote and secure conferencing technology enables physician to consult, collaborate and share data Founded in 2020, Abdul Latif Jameel Health was created as a response to the ongoing […]
...